Mah Kheirabadi

Mah Kheirabadi, PhD, currently serves as the Director of Discovery Chemistry at Entrada Therapeutics, where leadership in discovery chemistry has supported candidate nominations across various therapeutic areas, including neuromuscular and ocular programs. Previous roles include Senior Scientist II at Neon Therapeutics, overseeing a team in medicinal chemistry for TLR7/8 agonists, and Research Scientist positions at Bristol-Myers Squibb, focusing on automated flow chemistry and novel purification technologies for cyclic peptides. Mah has also contributed to peptide and small molecule purification and characterization at Spectrix Analytical Services. An academic foundation includes a B.Sc. in Chemistry from Sharif University of Technology and a PhD in Organic Chemistry from Temple University, complemented by experience as an adjunct instructor and research assistant at the latter institution.